Herpes simplex virus type 1 (HSV-1)
Showing 1 - 25 of >10,000
Herpes Simplex-virus Type 1 (HSV-1) Reactivation
Recruiting
- Tracheobronchitis
- Herpes Simplex Infection
- Patients with herpes-simplex infection requiring bronchoscopy
-
Münster, GermanyUniversity Hospital Münster
Apr 11, 2022
HSV, Herpes Labialis Trial in Saint Paul (Squaric Acid Dibutyl Ester)
Completed
- HSV
- Herpes Labialis
- Squaric Acid Dibutyl Ester
-
Saint Paul, MinnesotaPrism Clinical Research, LLC
Oct 5, 2021
Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)
Not yet recruiting
- Genital Herpes Simplex Type 2
- BNT163
- Placebo
- (no location specified)
Jun 21, 2022
Virus, HSV-1, Herpes Simplex 1 Trial in Pocatello, Saint George (Purell Hand Sanitizer, Medical Grade Mineral Oil)
Recruiting
- Virus
- +3 more
- Purell Hand Sanitizer
- Medical Grade Mineral Oil
-
Pocatello, Idaho
- +2 more
Nov 13, 2023
NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2
Suspended
- HSV-2 Infection
- Herpes Simplex Virus Infection
- Diagnostic Test: NOWDx HSV-2 Test
-
Tempe, Arizona
- +2 more
Sep 29, 2022
Herpes Simplex Trial in Tokyo (HSVTI Formulation 1, HSVTI Formulation 2, Placebo)
Not yet recruiting
- Herpes Simplex
- HSVTI Formulation 1
- +2 more
-
Tokyo, JapanGSK Investigational Site
Aug 4, 2023
Frequency of Symptomatic Herpes Virus I and II in HIV Infected
Recruiting
- HIV Disease
- +2 more
- Blood draw
-
Los Angeles, CaliforniaGlobal Research Institute
Apr 9, 2023
Herpes Labialis Trial in Germany (drug, behavioral, procedure)
Active, not recruiting
- Herpes Labialis
- HDIT101 (blinded therapy)
- +5 more
-
Berlin, Germany
- +4 more
Jan 26, 2023
Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +9 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Linyi, Shandong, ChinaLinyi Central Hospital
Jul 25, 2023
Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +8 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Jiangsu, ChinaXuzhou Second People's Hospital
May 8, 2023
Recurrent Genital Herpes Trial (UB-621)
Not yet recruiting
- Recurrent Genital Herpes
- UB-621
- (no location specified)
May 16, 2022
Protein Biomarkers in Neonatal Herpes Simplex Virus Infection
Completed
- Neonatal Herpes Simplex Infection
- +7 more
-
Copenhagen, Denmark
- +1 more
Dec 25, 2022
Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Ovarian Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 26, 2023
Genital Herpes Trial in United States (mRNA-1608, BEXSERO)
Recruiting
- Genital Herpes
- mRNA-1608
- BEXSERO
-
Birmingham, Alabama
- +24 more
Sep 11, 2023
Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Head and Neck Cancer
- +6 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, ChinaEye & ENT Hospital of Fudan University
Apr 13, 2023
Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1
Recruiting
- Lung Cancer
- +11 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Anqing, Anhui, ChinaThe PLA Navy Anqing Hospital
May 23, 2023
Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?
Recruiting
- Cervical Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 31, 2023
Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))
Recruiting
- Osteosarcoma
- +3 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Xi'an, Shaanxi, ChinaXi'an Honghui Hospital
May 8, 2023
Melanoma Trial in Beijing (OH2 injection, HX008 injection)
Recruiting
- Melanoma
- OH2 injection
- HX008 injection
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jan 28, 2023
Genital Herpes Trial in Seattle (acyclovir, valacyclovir)
Completed
- Genital Herpes
-
Seattle, WashingtonUniversity of Washington Virology Research Clinic
Nov 16, 2021
Herpes Simplex Virus Keratitis Trial in New York (oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily, oral acyclovir 400 mg
Withdrawn
- Herpes Simplex Virus Keratitis
- oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily
- oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops
-
New York, New YorkNew York University School of Medicine
Dec 29, 2021
Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)
Active, not recruiting
- Breast Cancer
- +3 more
- Talimogene laherparepvec
- Paclitaxel
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022
HSV Infection Trial (walnut extract)
Completed
- HSV Infection
- walnut extract
- (no location specified)
Oct 16, 2023